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Tau aggregation and progressive neuronal degeneration in
the absence of changes in spine density and morphology
after targeted expression of Alzheimer's disease-relevant
tau constructs in organotypic hippocampal slices
Abstract
Alzheimer's disease (AD) is characterized by progressive loss of neurons in selected brain
regions, extracellular accumulations of amyloid beta, and intracellular fibrils containing
hyperphosphorylated tau. Tau mutations in familial tauopathies confirmed a central role of
tau pathology; however, the role of tau alteration and the sequence of tau-dependent
neurodegeneration in AD remain elusive. Using Sindbis virus-mediated expression of
AD-relevant tau constructs in hippocampal slices, we show that disease-like tau modifications
affect tau phosphorylation at selected sites, induce Alz50/MC1-reactive pathological tau
conformation, cause accumulation of insoluble tau, and induce region-specific
neurodegeneration. Live imaging demonstrates that tau-dependent degeneration is associated
with the development of a "ballooned" phenotype, a distinct feature of cell death. Spine
density and morphology is not altered as judged from algorithm-based evaluation of dendritic
spines, suggesting that synaptic integrity is remarkably stable against tau-dependent
degeneration. The data provide evidence that tau-induced cell death involves apoptotic as
well as nonapoptotic mechanisms. Furthermore, they demonstrate that targeted expression of
tau in hippocampal slices provides a novel model to analyze tau modification and
spatiotemporal dynamics of tau-dependent neurodegeneration in an authentic CNS
environment.
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Tau Aggregation and Progressive Neuronal Degeneration in
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Alzheimer’sdisease (AD) is characterizedbyprogressive lossofneurons in selectedbrain regions, extracellular accumulationsof amyloid
, and intracellular fibrils containing hyperphosphorylated tau. Tau mutations in familial tauopathies confirmed a central role of tau
pathology; however, the role of tau alteration and the sequence of tau-dependent neurodegeneration inAD remain elusive. Using Sindbis
virus-mediated expression of AD-relevant tau constructs in hippocampal slices, we show that disease-like tau modifications affect tau
phosphorylation at selected sites, induce Alz50/MC1-reactive pathological tau conformation, cause accumulation of insoluble tau, and
induce region-specific neurodegeneration. Live imaging demonstrates that tau-dependent degeneration is associated with the develop-
ment of a “ballooned” phenotype, a distinct feature of cell death. Spine density andmorphology is not altered as judged from algorithm-
based evaluation of dendritic spines, suggesting that synaptic integrity is remarkably stable against tau-dependent degeneration. The
data provide evidence that tau-induced cell death involves apoptotic as well as nonapoptotic mechanisms. Furthermore, they demon-
strate that targeted expression of tau in hippocampal slices provides a novel model to analyze tau modification and spatiotemporal
dynamics of tau-dependent neurodegeneration in an authentic CNS environment.
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Introduction
Tau alteration and dysfunction and extensive neuron loss has
long been associatedwith several neurodegenerative diseases now
collectively called tauopathies. In tauopathies such as Alzhei-
mer’s disease (AD) and frontotemporal dementia and parkinson-
ism linked to chromosome 17 (FTDP-17), tau is abnormally and
hyperphosphorylated and is accumulated as intracellular neuro-
fibrillary tangles (NFTs) (Lee et al., 2001; Shahani and Brandt,
2002; Brandt et al., 2005). In AD, the tau pathology is joined by
the accumulation of extracellular amyloid plaques formed from
amyloid  (A) peptides. The identification of mutations in the
tau gene in FTDP-17 has confirmed that dysfunction of tau pro-
tein is central to the neurodegenerative process and that changes
in tau suffice to induce neuronal loss.
Abnormal phosphorylation of tau is considered one of the
earliest signs of neuronal degeneration and appears to precede
tau aggregation or amyloid formation (Braak et al., 1994). A good
correlation between the amount of hyperphosphorylated tau and
the clinical severity of AD patients has been demonstrated (Hol-
zer et al., 1994). Site-specific phosphorylation of tau can be reg-
ulated by concerted and sequential action of many protein ki-
nases and phosphatases (Iqbal et al., 2005; Stoothoff and
Johnson, 2005). These findings, and the changes in kinases and
phosphatases observed in AD (Iqbal et al., 2005), suggest that tau
hyperphosphorylation is likely to be caused by an imbalance of
the complex protein phosphorylation and dephosphorylation
systems.
Glutamate is commonly used as a mimic of phosphoserine or
phosphothreonine because of similar steric and electrostatic
properties (Huffine and Scholtz, 1996; Davis, 2004) and imitates
the effect of phosphorylation on the function of many proteins
(Maciejewski et al., 1995; Wang et al., 1998). We showed previ-
ously that tau constructs in which serine/threonine residues
(which are phosphorylated to a high extent in AD tau) were sub-
stituted with glutamate to create a pseudohyperphosphorylation
mimic key structural and functional aspects of hyperphosphory-
lated tau protein (Eidenmu¨ller et al., 2000, 2001; Maas et al.,
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2000), thus providing a model to test the effect of a disease-like
permanent and high stoichiometric tau phosphorylation. Inter-
estingly, pseudohyperphosphorylated tau (PHP tau) exerted a
neurotoxic effect when expressed in rat pheochromocytoma 12
(PC12) cells and human model neurons (Fath et al., 2002). It
should, however, be noted that mimicry of phosphoserine or
phosphothreonine with glutamate is limited to certain aspects,
because themutated residues are usually not detected by antibod-
ies that are specific for phosphorylated serine or threonine (Ei-
denmu¨ller et al., 2000).
Slice cultures combine the accessibility andmaintenance of in
vitro culture systems while preserving intact the hippocampal
synaptic circuitry and anatomy.Herewe show that tau constructs
are efficiently expressed in individual neurons of hippocampal
slices using recombinant Sindbis virus. The enhanced green flu-
orescent protein (EGFP) tag allows an excellent visualization of
all cellular compartments down to single dendritic spines of
proximal and distal dendrites. We show that tau modifications
induce region-specific neurodegeneration, cause accumulation
of insoluble tau, induce distinct pathological tau conformations,
and affect tau phosphorylation at selected sites. Three-
dimensional reconstructions of individual neurons suggest that
synaptic integrity is remarkably stable against tau-dependent
degeneration.
Materials andMethods
Materials. Chemicals were purchased from Sigma (Deisenhofen, Ger-
many). Cell culture media and supplements were obtained from Sigma
and Invitrogen (Gaithersburg,MD), and culture flasks, plates, and dishes
were obtained fromNunc (Roskilde, Denmark), unless stated otherwise.
Construction of Sindbis virus expression vectors. Eukaryotic expression
plasmids for adult [441 amino acids (aa)] and fetal (352 aa) human tau
with N-terminally fused EGFP were constructed in pHSV expression
vectors. PHP tauwas constructed by changing the codons for S198, S199,
S202, T231, S235, S396, S404, S409, S413, and S422 to glutamate as
described previously (Eidenmu¨ller et al., 2000). EGFP–tau [wild type
(wt) and PHP; adult and fetal isoform] cDNA was first subcloned into
pcDNA3.1 vector by EcoRI–XhoI sites. For recloning into pSinRep5 vec-
tor (a generous gift from Sondra Schlesinger, Washington University
School of Medicine, St. Louis, MO), EGFP–tau constructs were excised
from pcDNA3.1 vector using EcoRI, blunt-ended with Klenow fragment,
then cut with XbaI, and cloned into pSinRep5 plasmid, which was cut
previously with XbaI and PmlI. As a control, an expression vector was
constructed with EGFP alone. EGFPwas excised from pEGFP-C1 (Clon-
tech, Heidelberg, Germany) with BglII, blunt-ended with Klenow frag-
ment, then cut withNheI, and cloned into pSinRep5 plasmid, which was
cut previously with XbaI and PmlI.
pSinRep5–EGFP–tau constructs, pSinRep5–EGFP, and helper DH
(26S)DNA (which encodes the structural proteins of the Sindbis virus; S.
Schlesinger) were then transcribed in vitro (mMessage Machine SP6 kit;
Ambion, Huntingdon, UK). The recombinant RNA and helper DH
(26S) RNA were coelectroporated into baby hamster kidney (BHK) cells
using the Gene Pulser II electroporation system (Bio-Rad, Mu¨nchen,
Germany). The recombinant RNA encoding EGFP–tau or EGFP alone
was packaged and enveloped by the structural proteins produced by the
helper RNA. The replication-incompetent pseudovirions thus produced
and released into the extracellular mediumwere harvested after 24 h and
filtered and stored at80°C. The titer tested on BHK cells ranged from
1.7 to 3.0 108 infectious particles per milliliter for different constructs.
Organotypic hippocampal slice cultures and Sindbis virus infections.Or-
ganotypic slice cultures from hippocampus were prepared according to
the technique described by Stoppini et al. (1991). Six-day-old Naval
Medical Research Institute mice were decapitated, the brains were re-
moved, and the hippocampus of both sides were isolated and cut into
transverse slices of 400 m thickness on a McIlwain tissue chopper (Ga-
bler, Bad Schwalbach, Germany). The slices were then cultured on Mil-
lipore (Bedford, MA)membrane culture inserts (Millicell CM; pore size,
0.4 m) in six-well culture plates with 1 ml of slice culture media [50%
minimum essential medium (DMEM with HEPES modification), 25%
DMEM, 25% heat-inactivated horse serum, 2mM glutamine, 0.65% glu-
cose, pH 7.2] per well. The six-well culture plates were kept at 37°C in a
humidified atmosphere with 5% CO2. The slice culture media were
changed every third day. Slices were kept in culture for 12 d before the
experiments. After the first 8 d in culture, the slice culture medium was
replaced gradually with serum-free culture medium (Neurobasal me-
dium, pH 7.2, supplemented with N1, 2 mM glutamine, and 0.65% glu-
cose) as follows: (1) 50% serum medium/50% serum-free medium on
day 8 in vitro and (2) 100% serum-free medium on day 11. On day 12 in
vitro, the slice cultures were infected with the Sindbis virus by the droplet
method. For this, the virus stock was diluted (according to the experi-
ment) and was applied as a drop (1 l) on each hippocampal slice.
Infected slices were then used for different experimental purposes de-
scribed below.
Antibodies. The following primary antibodies were used, and specific-
ity and sources are given in parentheses: phosphorylation-independent
human tau antibodies: Tau-5 (mouse; PharMingen, San Diego, CA),
anti-human tau protein antiserum (rabbit; Biosource, Camarillo, CA);
phosphorylation-dependent and site-specific tau antibodies: AT270
(Thr-181; mouse; Pierce, Rockford, IL), pT205 (Thr-205; rabbit; Bio-
source), pT212 (Thr-212; rabbit; Biosource), pS214 (Ser-214; rabbit;
Biosource), pS262 (Ser-262; rabbit; Biosource), pS356 (Ser-356; rabbit;
Biosource); conformation-dependent tau antibodies: Alz-50 (7–9, 312–
342; mouse; a generous gift from Peter Davies, Albert Einstein College of
Medicine, Bronx, NY),MC1 (7–9, 312–342;mouse; P. Davies); anti-GFP
antibody (rabbit; Invitrogen). As secondary antibodies, cyanine 3 (Cy3)-
coupled anti-rabbit antibody (Dianova, Hamburg, Germany) and
peroxidase-conjugated anti-mouse and anti-rabbit antibodies (Jackson
ImmunoResearch, West Grove, PA) were used.
Immunohistochemistry. Infected hippocampal slices were left attached
on the insert membranes throughout the immunostaining protocol to
preserve the hippocampal structure and to ensure even penetration of
antibodies inside the tissue. Slices were first washed with PBS and fixed
with 4% paraformaldehyde in PBS containing 4% sucrose for 1 h at 4°C.
After washing with PBS, slices were treated with 0.4% Triton X-100 in
PBS for 90min and then 50mM ammonium chloride for 45min at room
temperature and blocked with PBS containing 5% fetal calf serum, 1%
BSA, 0.1% Triton X-100, and 0.02% NaN3 at 4°C overnight. Slices were
then incubated for 2–3 d at 4°C with primary antibodies diluted in PBS
containing 5% fetal calf serum, 1% BSA, 0.1% Triton X-100, and 0.1%
NaN3. After washing with PBS, they were incubated with Cy3-coupled
anti-rabbit antibody for 2 d at 4°C. The slices were then washed in PBS,
mounted in Confocal-Matrix (Micro-Tech-Lab, Graz, Austria) or
Vectashield (Vector Laboratories, Burlingame, CA), and coverslipped.
Confocal imaging of fixed and live hippocampal slices. All images were
acquired on Nikon (Tokyo, Japan) laser scanning microscope (Nikon
Eclipse TE2000-U inverted), equipped with C1 confocal laser scanning
unit, argon (Ar; 488 nm), helium/neon (He/Ne; 543 nm), and blue diode
(405 nm) lasers, and EZ-C1 software. Neurons expressing EGFP or EGF-
P–tau were visualized using the 488 nm argon laser line and 510–540 nm
bandpass emission filter. Cy3 was imaged using He/Ne 543 laser excita-
tion and 570–610 nm emission filter. Microscope objectives (Nikon)
used were a dry 4 [numerical aperture (NA), 0.13], a dry 20 (NA,
0.45; ELWD), an oil–water–glycerine 20 (NA, 0.75), an oil-immersion
60 (NA, 1.4), and an oil-immersion 100 (NA, 1.3). The microscope
was enclosed in an incubation chamber maintained at 37°C and 5%CO2
(Solent Scientific, Sagensworth, UK). For two-channel imaging of EGFP
and Cy3, images were acquired via sequential scanning. Image stacks
(typically 10–35 optical sections per stack; 1024  1024 pixels) were
collected for the whole hippocampal slice (30.45 m z-axis steps) and
different hippocampal subfields [CA1, CA3, and dentate gyrus (DG);
0.9–2.5 m z-axis steps] of the infected hippocampal slice fixed at day 3
postinfection. Maximum projection images were generated from the re-
sulting Z stacks.
Live imaging of infected neurons expressing EGFP alone or EGFP–tau
constructs in CA1, CA3, and DG regions of organotypic hippocampal
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slices was performed over a period of 4 d (day 2 to day 5 postinfection).
For these experiments (n  3), culture inserts were transferred to a
glass-bottom culture dish (MatTek, Ashland,MA) after the last change of
medium. Image stacks (20–35 optical sections per stack; 1024  1024
pixels) were collected at 0.45 m z-axis steps. Images were taken with
lowest practical laser (Ar; 488 nm) intensity and shortest practical illu-
mination time to limit photodynamic damage. By carefully marking the
culture plate orientation, the same region was scanned at different days.
Two-dimensional maximum projection images were reconstructed for
each region. For the quantitation of the extent of degeneration, the num-
ber of nondegenerating neurons (i.e., neurons without any swellings
having processes without any beading) was determined over time (day 3
and 4) and expressed relative to the number at day 2 postinfection from
the same microscopic field in different regions for all constructs. Evalu-
ations were performed blindly by a coworker without knowledge of the
identity of the samples.
For morphological analysis of spines, two neurons per construct and
per hippocampal subregion were completely imaged at high resolution.
Image stacks were captured in a montage man-
ner by translating the x–y stage to adjacent mi-
croscopic fields until the cell was completely
contained within the stacks (pixel size, 0.086
0.086 0.25m; one channel at 12 bit; 60 oil
objective; NA, 1.4). To yield a complete map of
the neurons, two-dimensional projections of
the image stacks were generated, aligned using
Adobe Photoshop (Adobe Systems, San Jose,
CA), and dendritic segments assigned to sub-
classes according to the criteria of Megias et al.
(2001). To improve spatial resolution and
signal-to-noise ratio, the image stackswere pro-
cessed using adaptive blind deconvolution (25
iterations; Autoquant,Watervliet, NY). The de-
convolved stacks were dissected, and traversing
axons and other processes were cropped away
and grouped according to their dendritic type.
Spine detection and measurements of spine
densities, lengths, and volume were performed
by algorithm-based evaluation using the auto-
matedmorphometric software package 3DMA-
Neuron (Koh et al., 2002; Weaver et al., 2004)
on batches of groups of dendrite segments. For
every neuron, all dendritic segments of the re-
spective subclasswere combined and spine den-
sity calculated by dividing the total number of
spines by the total length. Spine length and vol-
umewere obtained from a total of 747 dendritic
segments from stratum radiatum thick and thin
by averaging over the mean spine length and
volume of every segment (segment lengths
varying between 15 and 150 m).
Assessment of cell death. Lactate dehydroge-
nase (LDH) release into the culture media was
determined fluorimetrically using the
CytoTox-ONE Homogeneous Membrane In-
tegrity Assay kit (Promega, Madison, WI) ac-
cording to themanufacturer’s protocol. The as-
say was performed on 96-well microplates and
read on Fluostar OPTIMA plate reader (BMG
Lab Technologies, Offenburg, Germany) at 544
nm excitation and 590 nm emission. LDH ac-
tivity was normalized to the EGFP fluorescence,
which was determined from the respective fu-
sion protein lysates (from caspase-3 experi-
ments) at different times after infection.
Caspase-3 activity was determined fluori-
metrically from the lysates of infected hip-
pocampal slices at different times after infection
using EnzChek Caspase-3 assay kit number 1
with N-CBZ-L-aspartyl-L-glutamyl-L-valyl-L-
aspartic acid/aminomethyl coumarin (AMC) substrate (Invitrogen) ac-
cording to the manufacturer’s protocol. The assay was performed on
96-well microplates and read on Fluostar OPTIMA plate reader at
355–10 nm excitation, 460 nm emission (for AMC) and 485 nm excita-
tion, and 520 nm emission (for EGFP). Caspase-3 activity was normal-
ized to the EGFP fluorescence of the respective fusion protein lysates.
For determination of DNA fragmentation, DNA was extracted from
four to eight hippocampal slices using the TACS apoptotic DNA ladder-
ing kit from R & D Systems (Wiesbaden, Germany) according to the
manufacturer’s protocol. Approximately 1g of DNA from each sample
was electrophoresed through 1.5% agarose in Tris acetic acid buffer,
visualized by ethidium bromide staining, and photographed under UV
illumination.
Immunoblot analysis. Cultured hippocampal slices (at different times
after infection) were harvested and sonicated in radioimmunoprecipita-
tion assay (RIPA) buffer (50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1% NP-40, 0.5% deoxycholate, and 0.1% SDS, pH 8.0) contain-
Figure 1. Sindbis-virus-mediated expression of EGFP-tagged human tau constructs in organotypic hippocampal slices. A,
Schematic representationof EGFP-taggedhuman tau constructs. The constructswerebasedon the longest adult (441aa) and fetal
(352 aa)wild-type tau isoformswith an amino terminally fused EGFP sequence (discontinuous gray box). Serine (S)/threonine (T)
residues, which have been substituted with glutamate (E) to create a pseudohyperphosphorylation of these residues, are indi-
cated. As a control, EGFP sequence alone was used. The microtubule-binding repeats of tau are indicated by the thick black box.
Adult-specific exons are shaded. B, C, Time course of EGFP expression in infected hippocampal slices. B, Lysates of the slices at
different times after infection were prepared and separated by 10% SDS-PAGE and immunoblotted with GFP antibody. C, The
graph shows the relative amounts of EGFP expressed at days 1–6 (d1–d6) postinfection. EGFP was detected as early as 7 h
postinfection (data not shown), peaked at around day 3, and persisted until 1 week. D, E, Time course of EGFP–tau expression in
infected hippocampal slices at d2, d4, and d6 postinfection (D) and the quantitation of results (E). Note that the kinetics of
expression of the different tau fusion proteins is very similar to EGFP alone. Lysates of slices at different times after infectionwere
prepared and analyzed by immunoblot using phosphorylation-independent antibody (Tau-5). Data are presented as mean
SEM from three independent experiments.
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ing protease inhibitors (1 mM PMSF, 10 g/ml each of leupeptin and
pepstatin, 1 mM EGTA) and phosphatase inhibitors (1 mM sodium or-
thovanadate, 20mM sodium fluoride, and 1mM sodium pyrophosphate)
and centrifuged for 15min at 13,000 g at 4°C. The supernatant (lysate)
was collected, frozen, and stored at80°C. Protein concentration of the
samples was determinedwith BCA (Pierce). Samples (10g of protein in
lysates) or recombinant tau proteins (0.1g of protein)were subjected to
SDS-PAGE and transferred to Immobilon-P (Millipore) followed by im-
munoblottingwith various antibodies against tau andGFP. As secondary
antibody, peroxidase-coupled anti-mouse or rabbit antiserum was used.
Detection used enhanced chemiluminescence using SuperSignal West
Dura extended duration substrate (Pierce) andwas performed according
to the manufacturer’s protocol. Quantification of the blots was per-
formed with Gel-Pro Analyzer 4.0 (Media Cybernetics, Silver Spring,
MD). To determine quantitatively alterations in EGFP–tau phosphory-
lation/conformation at different epitopes, all data obtained with
phosphorylation-dependent/conformation-dependent antibodies were
normalized to total tau levels in the samples, and differences in phos-
phorylation/conformation between EGFP–PHP tau and EGFP–wt tau
were determined.
Sequential extraction of EGFP–tau proteins. To study the solubility of
tau proteins in infected hippocampal slices, we generated a tau solubility
profile by applying a sequential extraction approach on hippocampal
slices using buffers of increasing stringency (Zhukareva et al., 2004). At
each extraction step, samples were sonicated briefly, spun at 45,000 g
for 30 min at 4°C, and supernatants were collected and subjected to
immunoblot analysis as described above. The following sequential series
of solubilizing buffers with amixture of protease and phosphatase inhib-
itors (described above) were used for extraction: (1) buffer A (high salt,
750 mMNaCl, 50 mM Tris buffer, pH 7.2), (2) 1% Triton in buffer A, (3)
RIPA buffer (50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1%
NP-40, 0.5% deoxycholate, and 0.1% SDS, pH 8.0), (4) 2% SDS, and (5)
70% formic acid (FA). FA samples were then diluted with distilled water
to a 20% final concentration of FA and lyophilized for at least 24 h.
Freeze-dried FA samples were reconstituted in the original volume of
0.1 M Tris-HCl, pH 7.5, and adjusted to pH 7.5 with NaOH. The same
amount from each extract was loaded per lane (6% of total extract).
Quantitative immunoblots were performed using Tau-5 antibody to de-
termine the tau level in each fraction.
Statistical analysis. Data were expressed as means SE (n 3–5). All
experiments were performed in triplicates or duplicates and repeated at
least three times. Statistical analysis among experimental groups was
performed using paired Student’s t test (Origin 7.0; Microcal Software,
Northampton, MA). p values are */°p  0.05, **/°°p  0.01, and ***/
°°°p 0.001.
Results
Targeted expression of EGFP-tagged human tau in
organotypic hippocampal slices permits high-resolution
imaging of individual neurons
To analyze the behavior of tau in neurons in an authentic CNS
environment, we prepared a panel of EGFP-tagged tau con-
structs and expressed them in cultured mouse hippocampal
slices. The constructs were based on the longest adult (441 aa)
and fetal (352 aa) CNS tau isoforms (Fig. 1A). Wild-type tau
and PHP tau sequences, which mimic key structural and func-
tional aspects of hyperphosphorylated tau protein (Eidenmu¨l-
ler et al., 2000; Maas et al., 2000; Fath et al., 2002), were
prepared and fused amino terminally with EGFP. The con-
structs were cloned in Sindbis viral vectors, which allows for a
targeted transient expression in different types of neurons in
hippocampal slice cultures (Ehrengruber et al., 1999; Maletic-
Savatic et al., 1999).
To determine the time course of expression, virus was applied
onto the hippocampal slices by the droplet method and lysates of
the slices at different times after infection were prepared and
analyzed by immunoblot. As a control, a construct with EGFP
sequence alone was used. EGFP was detected as early as 7 h
postinfection (data not shown), peaked at 3 d, and persisted
until 1 week (Fig. 1B,C). The kinetics of expression of the differ-
ent tau fusion proteins was very similar to EGFP alone (Fig.
1D,E).
Efficient infection of neurons in all regions of the hip-
pocampal slice was observed 3 d after application of the virus
as indicated by the intense EGFP fluorescence (Fig. 2A). At
higher magnification, many individual infected CA1 and CA3
pyramidal neurons as well as DG granule neurons were iden-
tified by their characteristic morphology and location (Figs.
2B–D). In addition, some interneurons in all regions were also
infected. EGFP fluorescence was present in cell bodies, pro-
cesses, and dendritic spines of the proximal and distal den-
drites and allowed high-resolution imaging at the level of in-
dividual spines for several days (Fig. 2E–G). At later time
points after infection (5 d), many fluorescent cells appeared
to have died in all hippocampal regions (data not shown).
Figure 2. Distribution of infected neurons in cultured hippocampal slices.A–D, Immunoflu-
orescencemicrographs of thewhole slice (A), CA1 region (B), CA3 region (C), and DG region (D)
of EGFP–tau-infected slices 3 d postinfection. Note efficient infection of neurons in all regions.
E–G, High-power magnifications of a single CA3 pyramidal neuron (E) and sections of the
proximal (F ) and distal (G) dendrites. Note intense EGFP fluorescence in all cellular compart-
ments. Slices were fixed and processed for immunofluorescence as described in Materials and
Methods. so, Stratum oriens; sp, stratum pyramidale; sr, stratum radiatum; slm, stratum lacu-
nosum-moleculare; sm, stratum moleculare; sg, stratum granulosum. Scale bars: A, 300m;
B–E, 50m; F, G, 10m.
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Tau-dependent neurodegeneration occurs region specifically
in organotypic culture
To determine a potential cytotoxic effect of tau expression in
cultured hippocampal slices, release of LDH as a marker for
plasma membrane damage was analyzed fluorimetrically at dif-
ferent times after infection. LDH activity was normalized to the
EGFP fluorescence, which was determined from the respective
lysates. In most experiments, expression of adult or fetal wt tau
caused only a small increase in LDH release comparedwith EGFP
alone at 3 and 4 d postinfection (Fig. 3A). In contrast, PHP tau
expression resulted in an 100% increase in LDH release. Both
adult and fetal PHP tau induced a significant increase in compar-
ison to the respective wild-type isoform. We did not observe an
obvious difference between the different isoforms (adult wt vs
fetal wt tau or adult PHP vs fetal PHP tau) or at different times
after infection.
To determine the mechanisms that are associated with the
PHP tau-induced neurodegeneration, activation of caspase-3 as a
marker for apoptotic events was assayed fluorimetrically and
normalized to the EGFP fluorescence of the respective fusion
protein. Caspase-3 activity was significantly increased for the
PHP tau constructs compared with wt tau or EGFP alone in the
infected hippocampal slices (Fig. 3B). The pattern of caspase-3
activation for the different isoforms and time points after infec-
tion was very similar to that of LDH release, indicating that the
neurodegenerative effect of PHP tau is
closely associated with apoptotic mecha-
nisms. Support for an apoptotic contribu-
tion to PHP tau-induced cell death was
provided by the appearance of DNA frag-
mentation revealed by agarose gel electro-
phoresis (Fig. 3C). The fragmentation pat-
tern was very similar to the fragmentation
induced by the typical apoptosis inducer
staurosporine (Gianinazzi et al., 2004).
To determine the spatiotemporal dy-
namics of tau-induced neurodegenera-
tion, we performed live imaging of
infected neurons expressing the EGFP-
tagged constructs in the CA1, CA3, and
DG regions over a period of 4 d. We ob-
served a time-dependent loss of individual
neurons in all hippocampal regions and
with all constructs (Fig. 4A,B, asterisks).
In addition, in CA3 and DG, many PHP
tau-expressing neurons developed a “bal-
looned” phenotype characterized by a
swollen neuronal perikaryon starting at
day 3 postinfection for the adult isoform
(Fig. 4B, arrowheads) and day 4 for the
fetal isoform. Ballooned neurons with and
without apparent processes were ob-
served. It was not possible to preserve bal-
looned neurons by standard fixation
procedures, suggesting that they had lost
their contacts and cytoskeletal integrity. It
should be noted that the development of a
ballooned phenotype is considered to be
distinct from apoptosis (Gleckman et al.,
1999), indicating that tau-induced cell
death involves apoptotic as well as non-
apoptotic mechanisms.
To quantitate the extent of degenera-
tion, the number of nondegenerating neurons (i.e., neurons
without any swelling having processes without beading) was de-
termined over time (day 3 and 4) and expressed relative to the
number at day 2 postinfection from the samemicroscopic field in
different regions for all constructs (Fig. 4C–E). In theCA1 region,
tau expression resulted in a slight reduction of the number of
nondegenerating neurons compared with neurons expressing
EGFP alone (Fig. 4C).Wedid not observe a difference betweenwt
tau- and PHP tau-expressing neurons. In contrast, in CA3 and
DG regions, the number of nondegenerating neurons expressing
the PHP tau isoforms dramatically decreased compared with
neurons expressing EGFP alone or wt tau isoforms (Fig. 4D,E).
Neurons expressing the adult isoform of PHP tau degenerated
earlier (day 3) than fetal PHP tau-expressing neurons, in which
the majority of neurons were degenerated only at day 4.
Collectively, the data indicate that the PHP modification in-
duces a region-specific neurodegeneration in the CA3 and DG
subfields of hippocampal slices and that cell death involves both
apoptotic and nonapoptotic mechanisms.
Spine density and spine morphology are stable against
tau-induced degeneration
In AD, alterations in synaptic integrity and plasticity have been
reported as an early event (Selkoe, 2002; Coleman and Yao,
2003); however, it is unclear whether synaptic changes are attrib-
Figure 3. Effect of tau expression on LDH release, caspase-3 activity, and DNA fragmentation. A, Release of LDH from the
infectedhippocampal slices at 3 (left) and4 (right) dayspostinfection. Bothadult (441) and fetal (352) PHP tau inducea significant
increase compared with the respective wt isoform or EGFP alone. B, Caspase-3 activity after 3 (left) and 4 (right) days postinfec-
tion. Caspase-3 activity is significantly increased for the PHP tau constructs compared with wt tau or EGFP alone in the lysates of
infectedhippocampal slices at different times after infection (day 3–4).C, DNA fragmentation after 3 dpostinfection or treatment
with staurosporine (Stp). The pattern of DNA damage for the PHP tau constructs was similar to that induced by the typical
apoptosis inducer staurosporine (10M; 6 h). LDH and caspase-3 activity were assayed fluorimetrically and normalized to the
EGFP fluorescence of the respective fusion protein. All values are shown as the mean SEM from at least three independent
experiments. Data for EGFP–wt or PHP tau are expressed as percentage of the value for EGFP alone. Data were analyzed using
Student’s t test and considered to be significantly different from EGFP–wt tau at *p 0.05, **p 0.01, and ***p 0.001. For
the assay for DNA fragmentation, samples were separated by agarose gel electrophoresis on 1.5% agarose. Similar results were
obtained by two independent experiments. M, Marker.
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utable to the amyloid or the tau pathology.
To determine tau-dependent effects on
spine density and spine morphology,
EGFP–tau-expressing neurons in the CA1
and CA3 regions of organotypic hip-
pocampal slices at day 3 postinfectionwere
analyzed. At these conditions, PHP tau-
induced neurodegenerationwas evident in
the CA3 region but not in CA1 (Fig. 4).We
acquired high-resolution images of com-
plete neurons, which allows for detailed
spine analysis of the complete dendritic ar-
bors and every type of dendrite. To avoid
restricting the evaluation to a too-narrow
domain a priori, we included the total den-
dritic segments of the neuron in the anal-
ysis. The segments were assigned to five to
seven subclasses to confine the typically
high variance of spine densities within
parts of the dendritic field (Fig. 5A). Spine-
related parameters were determined by
automated algorithm-based morphome-
try as described inMaterials andMethods.
Spine densities in the different dendritic
subclasses ranged between 0.5 (stratum lu-
cidum) and 2.5 per micrometer (stratum
radiatum). They were maximal in the
proximal stratum radiatum and decreased
distally in the CA1 neurons. We did not
observe an obvious difference in spine
densities between wt and PHP tau-
expressing neurons for both isoforms in
any hippocampal region or dendritic sub-
class (Fig. 5B,C). The mean length and
volume of spines were 0.94 m (0.12
m; SEM) and 0.41 m3 (0.09 m3;
SEM), respectively, for all dendritic seg-
ments evaluated and similar for wt and
PHP tau-expressing neurons (Fig. 5D).
The data suggest that synaptic integrity is
remarkably stable against tau-dependent
degeneration, providing evidence that alter-
ations in synapticplasticity inADaredirectly
caused by the amyloid pathology rather than
by tau-mediatedmechanisms.
Disease-like tau modifications cause
accumulation of insoluble tau, induce
pathological tau conformation, and affect tau
phosphorylation at selected sites
Filamentous tau aggregates that can be biochemically isolated
from diseased brain tissue are hallmarks of tauopathies such as
Alzheimer’s disease (Selkoe et al., 1982). To determine whether
tau becomes insoluble in infected slices, we generated a tau solu-
bility profile by applying a sequential extraction approach on
hippocampal slices using buffers of increasing stringency (Fig.
6A) (Zhukareva et al., 2004). In wt tau-infected slices, the major-
ity of tau was soluble and present in the high salt extract (80%),
and almost no insoluble tau (1%) was detected. In contrast, a
significant portion of PHP tau was insoluble (5–6%), indicating
the presence of aggregated tau. Tau was not detected in the 70%
formic acid fraction implicating the absence of highly insoluble
tau species. Interestingly, fetal tau isoforms (wt andPHP) showed
a different solubility profile compared with the respective adult
isoforms with the fetal tau isoforms generally requiring a higher
stringency buffer for extraction.
To test whether the accumulation of insoluble tau is associ-
ated with an induction of pathological tau conformation, immu-
noblots with Alz50 and MC1 antibodies were performed. Both
antibodies recognize a conformational epitope in AD brains that
depends on two discontinuous portions of the tau sequence as
shown in Figure 6B (Jicha et al., 1997) and that appears to be one
of the earliest pathological alterations of tau in AD (Wolozin et
al., 1986; Uboga and Price, 2000; Weaver et al., 2000). Both anti-
bodies showed slight reactivity against recombinant tau isoforms
(data not shown). In lysates of infected hippocampal slices, a
strong increase in immunoreactivity for the PHP tau proteinswas
observed, whereas the signal for the wt proteins remained low
Figure 4. Live imaging of the effect of tau expression on the survival of individual neurons in hippocampal slices. A, B,
Fluorescence micrographs of the CA1 region (A) and CA3 region (B) of living hippocampal slices 2 and 3 d postinfection. Time-
dependent loss of individual neurons was observed in all hippocampal regions (A, B, asterisks) and with all constructs, which
appeared higher in the CA3 region for PHP tau (B). In addition, in CA3 and DG, many PHP tau expressing neurons developed a
ballooned phenotype characterized by a swollen neuronal perikaryonwith orwithout processes (arrowheads). Scale bars:A,B, 50
m. C–E, Percentage of nondegenerating neurons (i.e., neurons with unaffected perikarya and processes) at days 2, 3, and 4
postinfection and expressed relative to the number at day 2 postinfection. In CA3 (D) and DG (E) regions, but not in the CA1 (C)
region, the number of nondegenerating neurons expressing the PHP tau isoforms dramatically decreased comparedwith neurons
expressing EGFP alone or wt tau isoforms. All values are shown as themean SEM from at least three independent experiments
(C–E). Thedata for EGFPaloneor EGFP–wtor EGFP–PHP tau (at day3or day4) are expressedas percentageof the respective value
for day 2 postinfection. Data were analyzed using Student’s t test and considered to be significantly different from EGFP alone at
*p 0.05, **p 0.01, and ***p 0.001 or from EGFP–wt tau at °p 0.05, °°p 0.01, and °°°p 0.001.
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(Fig. 6C). Quantitative analysis confirmed the conformational
alteration for PHP tau for both adult and fetal tau isoforms at
different times after infection (Fig. 6D,E). Practically all infected
neurons were stained with the MC1 antibody with a subcellular
distribution that closely reflected the EGFP fluorescence (Fig.
6F), indicating that this pathological alteration occurs in all pro-
cesses and all infected cells.
Abnormal phosphorylation may be involved to generate a
conformational state that is typical for the disease. To determine
whether pseudohyperphosphorylation of
tau induces abnormal phosphorylation in
hippocampal slices expressing tau con-
structs, immunoblot analysis using a panel
of phosphorylation-dependent and site-
specific antibodies against selected serine
and threonine residues was performed
(Fig. 7A). None of these antibodies was re-
active against recombinant wt or PHP tau
with the exception of an antibody against
phosphorylated S356, which was less reac-
tive with PHP tau isoforms comparedwith
wild-type tau (10–40% for the fetal and
adult isoform, respectively). In lysates of
infected hippocampal slices, we observed a
change in phosphorylation at several sites
compared with the respective wt tau con-
structs (Fig. 7B). A strong increase in
phosphorylation was seen with both adult
and fetal PHP tau isoforms at T212, S214,
and S262. In contrast, a marked decrease
was observed at T205. The amount of total
tau as determined using a phosphory-
lation-independent antibody (Tau-5) was
very similar for both isoforms (wt and
PHP tau). Quantitative analysis confirmed
increased phosphorylation for PHP tau
(30–150% compared with the respective
wt tau isoform) at T212, S214, and S262
for both adult and fetal tau isoforms at dif-
ferent times after infection (Figs. 7C–F). A
significant increase in phosphorylation at
S356 (50–60%) was observed for the fetal
PHP tau isoform (Fig. 7D,F). A slight in-
crease (10–30%) was also observed for
T181. At all conditions, phosphorylation
at T205 was strongly decreased (40–70%)
for PHP tau.
To determine the distribution of exog-
enously expressed tau and the different
phosphoisoforms, immunohistochemis-
try of infected hippocampal slices was per-
formed. Tau was present in all infected
(EGFP-positive) neurons and exhibited a
strong staining in processes and cell bodies
as detected using a phosphorylation-
independent polyclonal antibody against
human tau (Fig. 8A). Immunostainings
with the phosphorylation-dependent and
site-specific antibodies confirmed phos-
phorylation of the exogenously expressed
tau proteins at the respective sites.With all
antibodies, only infected neurons in all re-
gions were immunoreactive (Fig. 8B–D
and data not shown). Within the population of stained neurons,
marked differences in the antibody stainings compared with the
EGFP fluorescence were observed. In particular, most interneu-
rons in different zones (e.g., in theCA1 region) showed onlyweak
or no immunoreactivity against selected antibodies (Fig. 8B–D,
arrowheads); however, exceptions were also observed (Fig. 8B,
asterisk). For some antibodies, staining was prominent only in
cell bodies (Fig. 8C), whereas others also showed staining in pro-
cesses (Fig. 8B,D).
Figure 5. Spine density and spine morphology of tau-expressing neurons in hippocampal slices. A, Complete map of an
individual neuron of the CA1 (left) and CA3 (right) region infectedwith EGFP–tau. Segments are assigned to dendritic subclasses.
Scale bar, 100m. B, Representative dendritic segments after deconvolution from stratum radiatum thick and thin subclasses
fromCA1 and CA3 pyramidal neurons expressing tau constructs as indicated. Each framehas awidth of 30m. C, Spine density in
dendritic subclasses of CA1 and CA3 pyramidal neurons expressing adult (441) and fetal (352)wt and PHP tau constructs. Data are
based on the analysis of the complete dendritic arbor of two neurons per construct and per hippocampal region. Mean and range
are indicated. D, Spine length and volume in stratum radiatum thick and thin subclasses of CA1 and CA3 pyramidal neurons
expressing adult (441) and fetal (352)wt and PHP tau constructs. Datawere analyzed as described inMaterials andMethods from
a total of 747 dendritic segments. All values are shown as the mean SEM. St. Or, Stratum oriens; st. Luc, stratum lucidum; st.
Rad., stratum radiatum; st. L-M, stratum lacunosum-moleculare; prox, proximal; med, medial; dist, distal.
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The data indicate that abnormal phos-
phorylation at selected sites, induction of
pathological tau conformation and forma-
tion of tau aggregates are closely associated.
Discussion
Imaging and evaluation of
synaptic morphology
We expressed the cytoskeletal protein tau
tagged with EGFP using the neurotropic,
recombinant Sindbis virus, which pro-
vides an efficient, transient expression of
the fusion proteins in individual neurons
of hippocampal slices. Because EGFP ex-
pression revealed the detailed morphology
of living neurons, wewere able to follow and
image structural changes of the sameneuron
over a time course of several days. EGFP la-
beling also allowed us a high-resolution im-
aging and algorithm-based evaluation of the
neuronalmorphology at the level of individ-
ual spines in fixed tissue.
A number of studies have indicated al-
terations in synaptic integrity and plastic-
ity as an early phenotypic manifestation in
the pathogenesis of AD (Selkoe, 2002;
Coleman and Yao, 2003). Synapse density
is significantly decreased in the AD brain
(Terry et al., 1991), and the level of synapse
loss provides a better correlate of the pat-
tern and severity of cognitive impairment
than amyloid plaques and NFTs (Terry et
al., 1991). Also, in the hippocampus, there
is a progressive loss of dendritic spines
from pyramidal neurons in AD (el
Hachimi and Foncin, 1990; Ferrer and
Gullotta, 1990). In addition to the loss of
synapses, the dendrites of affected neurons
in AD show a dystrophic pattern and an
accumulation of phosphorylated tau
epitopes (McKee et al., 1989; Kowall and
McKee, 1993; Su et al., 1994a). By deter-
mining spine density and spine morphol-
ogy of tau-expressing neurons, we demon-
strated that PHP tau expression does not
induce major alterations in dendritic
spines of the infected neurons at the con-
ditions in which neuronal degeneration
was evident in the hippocampal slices. The
data suggest that in our tau pathology
model, synaptic connectivity is remark-
ably stable against tau-mediated degener-
ation. Thus, the decrease in synaptic den-
sity in AD is probably not caused by a
specific tau-dependent mechanism but is
caused by the amyloid pathology.
Mechanisms of cell death
AD and other neurodegenerative diseases
are characterized by progressive cell loss of
specific neuronal populations, but the underlying molecular
mechanisms that are responsible for the temporally and spatially
defined cell death are still unresolved. Postmortem analysis of
human brain has shown apoptotic DNA fragmentation (Su et al.,
1994b; Lassmann et al., 1995; Smale et al., 1995) and elevated
levels of caspase-3 activity (Gervais et al., 1999; Su et al., 2001) in
AD patients. On the other hand, several animal models for
tauopathies provided evidence for nonapoptotic neurodegenera-
Figure 6. Accumulation of insoluble tau and induction of pathological tau conformation after targeted tau expression. A, Tau
solubility profile from lysates of infectedhippocampal slices. Theprofilewasgeneratedusingbuffers of increasing stringency: high
salt, 1% Triton, RIPA buffer, 2%SDS, and 70% formic acid. Inwt tau (441 and 352 isoform)-infected slices, themajority of tauwas
soluble and present in the high salt extract with almost no insoluble tau. In contrast, a significant portion of PHP tau isoforms
was insoluble. No tauwasdetected in the70%formic acid fraction. Anequal amount of thematerial fromeachextraction stepwas
loaded, and Tau-5 antibody was used for immunoblot analysis. B, Schematic representation that indicates the epitopes of the
conformational-dependent antibodies Alz50 and MC1. C, Immunoblot of lysates of infected hippocampal slices. The PHP tau
proteins showed a strong increase in immunoreactivity for Alz50 and MC1 antibodies compared with the respective wt proteins.
D, E, Quantitation of the immunoblots. Conformational alteration for PHP tauwas increased for both adult and fetal tau isoforms
at different times after infection (day 3 andday 4). To determine quantitatively the alterations in EGFP–tau conformation, all data
obtained with conformation-dependent antibodies were normalized to total tau (Tau-5) levels in the samples, and then the
difference in conformation between EGFP–PHP tau and EGFP–wt tau was determined. Data for EGFP–PHP tau are expressed as
percentage of the value for EGFP–wt tau (wt tau set as 100%). All values are shown as themean SEM from three independent
experiments. Data were analyzed using Student’s t test and considered to be significantly different from EGFP-wt tau at *p
0.05, **p 0.01, and ***p 0.001. F, Double immunofluorescence staining of all infected neurons stained with the MC1
antibody showed a subcellular distribution closely reflecting the EGFP fluorescence. Scale bar, 100m.
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tion (Allen et al., 2002; Zehr et al., 2004). However, because of the
chronic nature of AD and other tauopathies, the relative contri-
bution of apoptosis is difficult to assess and other mechanisms
may also contribute to the massive neuronal death. Genetic anal-
yses have established a clear cause-and-effect relationship be-
tween tau alteration and neuronal cell death and dementia in
FTDP-17, but the mechanisms, which render tau to become a
toxic agent, are still unclear.
We observed that disease-like taumod-
ification induced extensive cell death in
organotypic hippocampal cultures, which
is associated with apoptotic mechanisms
as indicated by an increase in caspase-3 ac-
tivity and typical DNA fragmentation. In
addition, many neurons specifically de-
generated by establishing a ballooned phe-
notype, as has also been reported for pa-
tients with AD and other tauopathies
(Dickson et al., 1986; Fujino et al., 2004).
In Pick’s disease, no clear association be-
tween neuronal DNA fragmentation and
the presence of structural abnormalities
such as ballooned neurons was observed
(Gleckman et al., 1999), indicating that
apoptosis and the development of a bal-
looned phenotype represent distinct
mechanisms of cell death. Thus, our data
provide evidence that tau-dependent de-
generation involves both apoptotic as well
as nonapoptotic mechanisms.
We observed that neurodegeneration
induced byPHP tau occurs predominantly
in the CA3 and DG region of the hip-
pocampal slices. This indicates that
disease-relevant tau modification do not
cause general toxicity but exert their neu-
rodegenerative effect in a region- and
neuron-type specific manner. In AD and
after hypoxic/ischemic insults, CA1 region
typically demonstrates profound vulnera-
bility to neuronal cell death (Schmidt-
Kastner and Freund, 1991; West et al.,
1994). Regional susceptibility similar to
that seen in our experiments has been re-
ported with human immunodeficiency vi-
rus transactivating protein TAT, prenatal
stress, and okadaic acid, in which pyrami-
dal cells in the CA3 region and granule
cells in DG are more sensitive compared
with pyramidal cells inCA1 (Runden et al.,
1998; Maragos et al., 2003; Zhu et al.,
2004). The mechanism of okadaic acid
toxicity is likely attributable to sustained
activation of the mitogen-activated pro-
tein kinase (MAP kinase) pathway
(Runden et al., 1998). Sustained MAP ki-
nase activation is seen after brief ischemic
episodes in the CA3 region of the hip-
pocampus (Hu and Wieloch, 1994), and
the MAP kinase family is one group of ki-
nases that has been implicated in the phos-
phorylation of tau in AD (Drewes et al.,
1992; Arendt et al., 1995; Pei et al., 2002)
and in other neuronal death models (Subramaniam et al., 2004).
The neurotoxic effect of PHP tau may be caused by a selective
disturbance of signal transduction cascades in CA3 pyramidal
neurons and DG granule neurons; however, the precise molecu-
lar events and the relationship to AD remain to be shown. It
should be taken into account that our approach results in the
presence of tau in all neuronal compartments, whereas endoge-
nous tau is enriched in the axon. Thismay cause the slight toxicity
Figure 7. Phosphorylation state of tau in infected neurons. A, Schematic representation that indicates the epitopes of
phosphorylation-sensitive antibodies detecting serine (S) and threonine (T) residues that were not mutated in PHP tau. B,
Immunoblot of lysates of infected hippocampal slices with different phosphorylation-sensitive antibodies. Note that some anti-
bodies show a strong increase in the staining of the PHP isoforms relative to total tau (Tau-5). C–F, Quantitation of the immuno-
blots. An increased phosphorylation for PHP tau was detected at T212, S214, and S262 for both adult and fetal tau isoforms
compared with the respective wt tau isoform at different times after infection. At all conditions, phosphorylation at T205 was
strongly decreased for PHP tau. To determine quantitatively the alterations in EGFP–tau phosphorylation at different epitopes, all
data obtained with phosphorylation-dependent antibodies were normalized to total tau (Tau-5) levels in the samples, and then
the difference in phosphorylation between EGFP–PHP tau and EGFP–wt tau was determined. The data for EGFP–PHP tau are
expressed as percentage of the value for EGFP–wt tau (wt tau set as 100%). All values are shown as themean SEM from three
independent experiments. Data were analyzed using Student’s t test and considered to be significantly different from EGFP–wt
tau at *p 0.05, **p 0.01, and ***p 0.001.
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observed after expression of wt tau but
would not explain the obvious difference
between wt tau and PHP tau. Further-
more, a relocation of tau from the axonal
to the somatodendritic compartment
where neurofibrillary tangles become ap-
parent is a characteristic event during the
development of tau pathology. Thus, the
presence of tau in the “wrong” compart-
ment could well be relevant for disease
progression.
Although PHP tau mimics key aspects
of hyperphosphorylation, including the
induction of structural and functional
changes, it does not longer participate in
the complex phosphorylation/dephos-
phorylation events occurring with “nor-
mal” tau protein. Whether this is relevant
for tau-mediated toxicity in disease in
which dephosphorylation of tau is drasti-
cally reduced (Matsuo et al., 1994) re-
mains to be shown.
Abnormal phosphorylation and
tau aggregation
Constructs with pseudophosphorylated
residues provide a tool to determine the
effect of disease-like tau modifications on
tau phosphorylation at selected sites.Here,
we show that pseudohyperphosphoryla-
tion increases phosphorylation at several
other sites including T181, T212, S214,
S262, and S356. Some of these sites are
known to be abnormally hyperphosphory-
lated in AD, constitute recognition sites
for some AD diagnostic antibodies, and
are also known to correlate with the sever-
ity of neuronal pathology (Augustinack et
al., 2002; Lauckner et al., 2003). Interest-
ingly, in one case (T205), a decreased
phosphorylation was observed. Previ-
ously, it has been shown that phosphory-
lated T205 is completely and specifically
dephosphorylated by protein phosphatase
2A as a result of microtubule depolymer-
ization (Merrick et al., 1996). This may
suggest that dephosphorylation at this res-
idue is indirectly induced by tau modifications as a result of a
disturbed microtubule array in PHP tau-infected neurons.
Changed phosphorylation of PHP tau was associated with an
induction of a pathological tau conformation as recognized by
Alz50 and MC1 antibodies. A conformational change defined by
an increased immunoreactivity against these antibodies is con-
sidered to be one of the earliest pathological alterations of tau in
AD (Wolozin et al., 1986; Uboga and Price, 2000; Weaver et al.,
2000).
The contribution of tau modification and tau aggregation to
the neurodegenerative process remains elusive. Both neuronal
loss and NFTs increase in parallel with the duration and severity
of illness, but the amount of neuronal loss exceeds by manyfold
the amount of NFTs accumulated (Gomez-Isla et al., 1997). Un-
fortunately, in the disease and allmousemodels, both features are
closely interweaved, which precludes analyzing the contribution
of each factor. Several cell culture and invertebrate animalmodels
(Drosophila melanogaster and Caenorhabditis elegans) now pro-
vide converging evidence that aberrant tau phosphorylation in
the absence of large tau aggregates can cause a neurodegenerative
phenotype similar to that seen in human tauopathies (for review,
see Brandt et al., 2005). In agreement, PHP tau also exerted a
neurotoxic effect in neural cells (PC12 cells and human model
neurons), with no evidence for the formation of tau aggregates
(Fath et al., 2002). When expressed in cultured hippocampal
slices, some aggregation of PHP tau was observed. Interestingly,
in contrast to cell free assembly reactions in which the PHPmod-
ification inhibited aggregation (Eidenmu¨ller et al., 2000), in-
creased aggregation of these constructs was observed in the slices.
This indicates that additional modifications (e.g., phosphoryla-
Figure8. Distribution of the infected neurons thatwere immunoreactivewith different phosphorylation-sensitive antibodies.
A–D, Representative images for the CA1 region of hippocampal slices with EGFP fluorescence (left), stained for the respective
antibodies (middle) and overlay (right). With all antibodies, only infected neurons were immunoreactive (B–D). Note that most
interneurons in different zones in the CA1 region showed only weak or no immunoreactivity against selected antibodies (B–D,
arrowheads) with some exceptions (B, asterisk). Some antibodies stained most prominently the cell bodies (C), whereas others
showed staining also in processes (B, D). Scale bars, 100m.
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tion events as described above) and cellular factors exist that
specifically act on PHP tau in the neurons and promote tau ag-
gregation and NFT formation. In fact, data from several mouse
models suggest that A42 fibrils or mutant amyloid precursor
protein accelerate the formation of NFTs in mouse strains ex-
pressing FTDP-17 mutated tau (Go¨tz et al., 2001; Lewis et al.,
2001). It will be interesting to systematically analyze the effect of
AD-relevant proteins on the aggregation of wt tau by infecting
organotypic slices from transgenic animals.
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